Información bibliográfica
GuíaWHO consolidated guidelines for the management of common childhood illness: management of asthma in children and adolescents and bronchiolitis in infants and young children
Año de publicación2026
Institución emisoraWorld Health Organization
Recomendación
Actualizada
Intravenous (IV) magnesium sulfate should be the preferred option for second-line therapy and IV short-acting beta2 agonist (SABA) the preferred option for third-line therapy in severe paediatric asthma exacerbations not responding to standard first-line therapy.
Recomendado a favor
Condicional
Certeza de la evidencia
Muy baja